We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Potential New Tool for Cervical Cancer Detection

By LabMedica International staff writers
Posted on 29 Dec 2014
Print article
Image: Comparison of between normal cervical tissue (top), tissue lesion (second row), photographic image (third row) and corresponding DMAP images (fourth row) (Photo courtesy of Biomedical Optics Express).
Image: Comparison of between normal cervical tissue (top), tissue lesion (second row), photographic image (third row) and corresponding DMAP images (fourth row) (Photo courtesy of Biomedical Optics Express).
Photoacoustic imaging (PAI) has the potential to be a quicker, cheaper, and less-invasive method for detecting and staging cervical cancer (CC), according to a new study.

Researchers at Central South University (Changsha, China) conducted 30 in vitro experiments with tissue samples representing different cancer stages, using PAI, a hybrid optical imaging technique that combines the high contrast of pure optical imaging with the high spatial resolution and the deep imaging depth of ultrasound. The technique involves short laser pulses, some of which are absorbed by the tissues and converted into heat, leading to rapid thermal expansion inside the tissues that produces ultrasonic waves. The generated waves are then detected by an ultrasonic sensor to form photoacoustic images of the tissues.

In each of the experiments, the researchers embedded one section of normal cervical tissue and one section of cervical lesion (from the same person) in a cylindrical phantom for simultaneous PAI. Part of each sample was also sent to histological evaluation for cross-PAI. By processing all of the imaging data, the researchers obtained a depth maximum amplitude projection (DMAP) image, which shows the PAI contrast of the sample. The researchers used hemoglobin as the contrast agent, since PAI is highly sensitive to abnormal angiogenesis, a hallmark of CC tumors.

The obtained DMAP images were analyzed to evaluate the extent of the angiogenesis for different clinical stages of CC. The results showed stronger absorption from the cervical lesions, relative to that of normal tissue. The difference in mean optical absorption (MOA) between normal tissue and CC lesions showed a statistical significance, and the MOA of the CC lesions were closely related to the severity of CC. The study was published in the January 2015 issue of Biomedical Optics Express.

“Due to the higher hemoglobin concentration, abnormal angiogenesis has higher optical absorptions in certain wavelengths than normal tissues,” said lead author assistant professor of biomedical engineering Jiaying Xiao, PhD. “The technique is noninvasive and can detect the lesions in the cervical canal, an area conventional methods fail to observe. The photoacoustic imaging can also evaluate the invasion depth of cervical lesions more effectively.”

In current clinical practice, the diagnosis of CC is mainly through the cervical screening followed by a necessary biopsy, but this method is labor consuming and expensive, and can only detect superficial lesions around the external cervical orifice. In contrast, PAI is sensitive to the abnormal angiogenesis deep in the biological tissue, and may be capable for the intact scanning both around the external orifice and in cervical canal.

Related Links:

Central South University


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Entamoeba Test
RIDASCREEN Entamoeba Test
New
RNA/DNA Extraction Instrument
QIAcube Connect Instrument

Print article

Channels

Microbiology

view channel
Image: Genetic testing can determine which drugs will work for patients with C. auris (Photo courtesy of Shutterstock)

Genetic Testing Could Improve Treatment for Virulent Multidrug-Resistant Fungus Candida Auris

Candida auris (C. auris), a multidrug-resistant yeast responsible for severe, life-threatening infections, was first identified in 2009. Since its discovery, it has spread globally, causing significant... Read more

Technology

view channel
Image: Human tear film protein sampling methods (Photo courtesy of Clinical Proteomics. 2024 Mar 13;21:23. doi: 10.1186/s12014-024-09475-8)

New Lens Method Analyzes Tears for Early Disease Detection

Bodily fluids, including tears and saliva, carry proteins that are released from different parts of the body. The presence of specific proteins in these biofluids can be a sign of health issues.... Read more

Industry

view channel
Image: The investment is in line with Danaher’s aim to accelerate the transition to precision medicine with AI-enabled diagnostics

Danaher Partners with Healthcare AI Company Innovaccer on Novel Digital and Diagnostic Solutions

Danaher Diagnostics LLC and Danaher Ventures LLC, two subsidiaries of Danaher Corporation (Washington, DC, USA), has formed an investment partnership with healthcare artificial intelligence (AI) company... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.